当前位置:首页 - 行情中心 - 洁特生物(688026) - 财务分析

洁特生物

(688026)

  

流通市值:15.58亿  总市值:15.59亿
流通股本:1.40亿   总股本:1.40亿

洁特生物(688026)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2023年年度实现净利润0.35亿元,每股收益0.25元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2023年年度最新股东权益115758.76万元,未分配利润41198.11万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2023年年度最新总资产162605.22万元,负债46846.46万元。

利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入463,097,581.69329,649,047.6196,649,386.6174,281,810.8
营业总成本419,977,982.61314,299,201.54193,774,458.1283,402,836.99
营业利润39,443,322.6614,437,235.813,120,911.64-8,164,495.07
利润总额38,319,960.3914,367,122.293,050,798.12-8,385,323.62
净利润35,098,693.2814,142,070.713,041,738.62-8,741,237.41
其他综合收益372,375.73---
综合收益总额35,471,069.0114,142,070.713,041,738.62-8,741,237.41
资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计770,947,880.57743,539,261.45753,876,969.68808,867,584.35
非流动资产合计855,104,330.04855,484,450.17829,444,750.88773,656,320.74
资产总计1,626,052,210.611,599,023,711.621,583,321,720.561,582,523,905.09
流动负债合计103,403,461.0993,390,551.494,495,212.29102,720,052.34
非流动负债合计365,061,184.14361,356,051.09355,649,773.47348,410,650.97
负债合计468,464,645.23454,746,602.49450,144,985.76451,130,703.31
归属于母公司股东权益合计1,156,965,623.981,143,364,970.631,132,365,4991,130,605,806.6
股东权益合计1,157,587,565.381,144,277,109.131,133,176,734.81,131,393,201.78
负债和股东权益合计1,626,052,210.611,599,023,711.621,583,321,720.561,582,523,905.09
现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计502,607,377.69364,870,706.55228,350,114.9113,846,781.35
经营活动现金流出小计367,801,023.85289,275,524.6190,613,145.7181,021,104.13
经营活动产生的现金流量净额134,806,353.8475,595,181.9537,736,969.1932,825,677.22
投资活动现金流入小计468,383,430.49459,522,569.17209,547,176.9270,357,044.95
投资活动现金流出小计535,808,895.46443,910,592.29278,942,164.1114,910,710.57
投资活动产生的现金流量净额-67,425,464.9715,611,976.88-69,394,987.18-44,553,665.62
筹资活动现金流入小计----
筹资活动现金流出小计17,952,677.3816,215,068.8814,463,175.81,763,127.43
筹资活动产生的现金流量净额-17,952,677.38-16,215,068.88-14,463,175.8-1,763,127.43
汇率变动对现金及现金等价物的影响5,444,138.155,654,352.57,477,649.68-1,083,213.4
现金及现金等价物净增加额54,872,349.6480,646,442.45-38,643,544.11-14,574,329.23
期末现金及现金等价物余额364,937,577.58390,711,670.39271,421,683.83295,490,898.71
最新报告期:2024-04-20
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
中泰证券谢木青0.400.490.612024-04-20
TOP↑